Innate regulators of tumour-directed T cell immunity
Status: This talk is in preparation - details may change
Status: This talk has been cancelled
Please contact for Microsoft Teams link.
Dr Barbara Maier is fascinated by mechanisms of immunosuppression and immunotherapy in solid tumours. Her main research
focus is myeloid cells in the tumour microenvironment and the draining lymph node, and how they shape anti-tumour immunity, cancer progression and invasion, and response to therapies. Dr Maier uses innovative single cell
approaches to decipher the molecular states of tumour-associated immune cells. Her research includes both
immune monitoring of patient’s tumour samples to directly assess disease complexity, as well as murine systems
modelling human disease as a flexible experimental system allowing to address mechanistic questions. Dr Maier’s
professional goal is to gain in-depth knowledge about processes shaping the tumour microenvironment and the
tumour-draining lymph node until progression to lymph node metastasis occurs. She aims to translate her mechanistic
findings into clinical studies, as her vision is to truly contribute to innovative, curative therapies for cancer patients.
Date: 15 May 2023, 11:00 (Monday, 4th week, Trinity 2023)
Venue: Venue to be announced
Speaker: Dr Barbara Maier (CeMM, Research Center for Molecular Medicine of the Austrian Academy of Sciences)
Organising department: Department of Oncology
Organiser: Annabelle Ziegler
Organiser contact email address:
Booking required?: Not required
Audience: Members of the University only
Editor: Yuliia Karpenko